Avant Immunotherapeutics CEO to Present at the 28th Annual Canaccord Adams Global Growth Conference

NEEDHAM, Mass.--(BUSINESS WIRE)--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Anthony S. Marucci, interim President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the 28th Annual Canaccord Adams Global Growth Conference at the InterContinental Hotel in Boston on Wednesday, August 13 at 4:00 pm, EDT.

MORE ON THIS TOPIC